Cytokines** | Unstimulated | TLR3 responses | TLR7/8 responses | TLR9 responses | ||||
---|---|---|---|---|---|---|---|---|
Crude | Crude | Ratios | Crude | Ratios | Crude | Ratios | ||
AHR (95% CI) | AHR (95% CI) | AHR (95% CI) | AHR (95% CI) | AHR (95% CI) | AHR (95% CI) | AHR (95% CI) | ||
Pro | IFN-α |  |  | 0.24 (0.05–1.10) |  |  |  |  |
IL-1RA* |  |  |  | 0.61 (0.36–1.03) | 0.70 (0.50–0.98) |  |  | |
IL-1β | 1.16 (0.98–1.37) | 1.15 (0.97–1.36) |  |  |  | 1.18 (1.01–1.39) |  | |
TNF | Â | Â | Â | Â | Â | Â | Â | |
Anti | IL-10 |  | 1.12 (0.99–1.25) |  |  |  |  |  |
IL-7 |  | 1.80 (1.26–2.58) | 1.54 (1.11–2.15) |  |  |  |  | |
Th1 | IL-15 |  |  |  |  |  | 1.22 (0.96–1.54) |  |
IL-12* | 1.28 (0.97–1.69) | 1.26 (0.95–1.68) | 0.27 (0.07–1.15) |  | 0.76 (0.59–0.98) |  | 0.46 (0.20–1.04) | |
IL-2 | Â | Â | Â | Â | Â | Â | Â | |
IL-2R | Â | Â | Â | Â | Â | Â | Â | |
IFN-γ |  |  |  |  |  |  |  | |
Th2 | IL-13 | Â | Â | Â | Â | Â | Â | Â |
IL-5 | Â | Â | Â | Â | Â | Â | Â | |
IL-4 | Â | Â | Â | Â | Â | Â | Â | |
Th17 | IL-17 | Â | Â | Â | Â | Â | Â | Â |
IL-6 | Â | Â | Â | Â | Â | Â | Â | |
Chemokines | IL-8 | Â | Â | Â | Â | Â | Â | Â |
IP-10* | 0.64 (0.38–1.08) | 0.66 (0.46–0.93) |  |  |  | 0.75 (0.59–0.96) |  | |
MCP-1 | Â | Â | Â | Â | Â | Â | Â | |
MIG |  |  |  |  |  |  | 0.77 (0.56–1.05) | |
MIP-1α |  |  |  |  |  | 1.13 (0.97–1.31) |  | |
MIP-1β |  |  |  |  |  |  |  | |
RANTES | Â | Â | Â | Â | Â | Â | Â | |
EOTAXIN | 1.83 (1.11–3.01) | 1.60 (0.99–2.58) | 0.19 (0.03–1.14) | 1.72 (1.01–2.94) |  |  | 0.46 (0.24–0.86) | |
Growth factors | EGF |  |  |  | 0.29 (0.08–1.07) |  |  |  |
FGF |  | 1.63 (0.91–2.93) |  |  |  |  |  | |
G-CSF | 1.24 (0.97–1.57) |  |  |  |  |  |  | |
GM-CSF* |  |  |  | 1.28 (1.01–1.15) |  |  |  | |
HGF | Â | Â | Â | Â | Â | Â | Â | |
VEGF | Â | Â | Â | Â | Â | Â | Â |